BACKGROUND: Pituitary @entity3 secondary to @entity1469 ( @entity1469 ) is an extremely rare condition that has not been previously reported in the literature. CASE: A 23-year-old female presented with symptoms of @entity2588 for 6 months. She was diagnosed with @entity1466 , and chemotherapy was scheduled. Three months after drug withdrawal she complained of @entity10 and @entity154 . Brain magnetic resonance images showed suprasellar and intrasellar space-occupying lesions. Pituitary @entity3 of @entity1466 was considered. She received @entity2879 , @entity1499 , @entity4316 , @entity2879 , and @entity900 multiagent chemotherapy combined with intrathecal @entity1499 administration. Complete radiological remission was obtained after cessation of chemotherapy. During the 13-month follow-up period no disease progression or recurrence was noted. CONCLUSION: Pituitary @entity3 of @entity1469 is possible and is a curable disease that should be considered in young @entity1 with a history of @entity1466 who have neurologic symptoms. This @entity3 responds well to chemotherapy.

XXXX Metastasis to the Pituitary: A Case Report.

@entity1 :: ('9606', 'Species') :: ['women'] @entity154 :: ('MESH:D000013', 'Disease') :: ['visualfield defects'] @entity1466 :: ('MESH:D002822', 'Disease') :: ['choriocarcinoma'] @entity900 :: ('MESH:D002945', 'Chemical') :: ['cisplatinum'] @entity1469 :: ('MESH:D031901', 'Disease') :: ['gestational trophoblastic neoplasia', 'GTN'] @entity2879 :: ('MESH:D005047', 'Chemical') :: ['etoposide'] @entity4316 :: ('MESH:D003609', 'Chemical') :: ['actinomycin'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis'] @entity1499 :: ('MESH:D008727', 'Chemical') :: ['methotrexate'] @entity10 :: ('MESH:D006261', 'Disease') :: ['headache'] @entity2588 :: ('MESH:D000568', 'Disease') :: ['amenorrhea']
@entity1469 :: (MESH:D031901,Disease) :: ['Gestational Trophoblastic Neoplasia']
